Delivery Order SPE2DB22D3004-SPE2DB25FPT08

Award Date 2/28/25
Potential Completion Date 3/21/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is for the delivery of 4567908489 YONSA 125 MG TABLET 120S. The contract is a Firm Fixed Price Delivery Order with a completion date of May 5, 2025. The contract was awarded on April 14, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 120 tablets of the medication YONSA 125 MG. The contract has an ultimate completion date of June 9, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $2,271.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB22D3009|SPE2DB25FAV90) for the medication YONSA 125 MG TABLET 120S, with a performance period extending to May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order with a Firm Fixed Price of $2,271.36 and an ultimate completion date of April 18, 2025. The contract is for the provision of YONSA 125 MG TABLET 120S, a pharmaceutical product. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D2103|SPE2DB25FR9AB, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.74 firm fixed-price delivery order contract is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025 and was awarded on March 21, 2025. It is not designated as a set-aside contract....
This federal contract award is a Delivery Order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, valued at $6,814.08, is for the supply of YONSA 125 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price agreement with an ultimate completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order, identified as SPE2DB22D3004|SPE2DB25FQJ25, is for the supply of 4567984090 YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 21, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,542.74 firm fixed-price delivery order is for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order with a ceiling value of $2,195.48 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of YONSA 125 MG TABLET 120S, a medication, with a period of performance through November 18, 2024. The contract type is Firm Fixed Price. This award is not associated with any set-aside designations, indicating open competition. AmerisourceBergen holds a $999,999,999...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPT08
    Delivery Order

This federal contract award, SPE2DB22D3004|SPE2DB25FPT08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $2,271.36, is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of March 21, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/30/25, 10:07 AM